Public signalCompany raiseAuto-indexed · Unverified
Vizgen, Inc. raised $3.5M
Vizgen, Inc.· CAMBRIDGE, US· Biotechnology· Filed Oct 7, 2025
Vizgen, Inc. reported raising capital. Based in CAMBRIDGE, MASSACHUSETTS, US. First sale reported 2025-10-01. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$3.5M
Confidence90%
Raised
$3.5M
Investors
7
Jurisdiction
DELAWARE
On the record
- Location
- CAMBRIDGE, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $3.5M
- Target amount
- $9.5M
- Filing date
- Oct 7, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Biotechnology
- Number of investors
- 7
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $9.5M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Andrea Jackson
Director
Waltham, US
Chris Guiffre
Executive Officer
Cambridge, US
Christian Urhich
Director
Cambridge, US
David Walt
Director
Walthalm, US
Keith Crandell
Director
Waltham, US
Matthew Posard
Director
Waltham, US
Robert Carson
Executive Officer
Waltham, US
Simona Levi
Executive Officer
Waltham, US
Terry Lo
Director
Cambridge, US
Sources & provenance
“Operating company sold 3,500,000 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Oct 7, 2025. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$1M – $10MCompany Raise
Are you associated with Vizgen, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record